Literature DB >> 35678998

NUCB2: roles in physiology and pathology.

Qing Zhou1,2, Ying Liu1,2, Ranran Feng1,2, Wenling Zhang3,4.   

Abstract

Nucleobindin2 (NUCB2) is a member of nucleobindin family which was first found in the nucleus of the hypothalamus, and had a relationship in diet and energy homeostasis. Its location in normal tissues such as stomach and islet further confirms that it plays a vital role in the regulation of physiological functions of the body. Besides, NUCB2 participates in tumorigenesis through activating various signal-pathways, more and more studies indicate that NUCB2 might impact tumor progression by promoting or inhibiting proliferation, apoptosis, autophagy, metastasis, and invasion of tumor cells. In this review, we comprehensively stated NUCB2's expression and functions, and introduced the role of NUCB2 in physiology and pathology and its mechanism. What is more, pointed out the potential direction of future research.
© 2022. The Author(s) under exclusive licence to University of Navarra.

Entities:  

Keywords:  Appetite regulation; Energy homeostasis; NUCB2; Tumorigenesis

Mesh:

Substances:

Year:  2022        PMID: 35678998     DOI: 10.1007/s13105-022-00895-4

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   5.080


  109 in total

1.  High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.

Authors:  Bolag Altan; Kyoichi Kaira; Shuichi Okada; Tsugumichi Saito; Eijiro Yamada; Halin Bao; Pinjie Bao; Kengo Takahashi; Takehiko Yokobori; Oyama Tetsunari; Masahiko Nishiyama; Masanobu Yamada
Journal:  Tumour Biol       Date:  2017-07

2.  Nesfatin-1 acts on the dopaminergic reward pathway to inhibit food intake.

Authors:  Xi Chen; Xin Shu; Zhu-Kai Cong; Zheng-Yao Jiang; Hong Jiang
Journal:  Neuropeptides       Date:  2015-08-01       Impact factor: 3.286

Review 3.  Recent progress in research on the distribution and function of NUCB2/nesfatin-1 in peripheral tissues.

Authors:  Xun Cao; Xiao-Min Liu; Li-Hong Zhou
Journal:  Endocr J       Date:  2013-08-14       Impact factor: 2.349

4.  The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.

Authors:  Ayhan Abaci; Gonul Catli; Ahmet Anik; Tuncay Kume; Ece Bober
Journal:  Pediatr Diabetes       Date:  2013-01-24       Impact factor: 4.866

5.  Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein.

Authors:  S Barnikol-Watanabe; N A Gross; H Götz; T Henkel; A Karabinos; H Kratzin; H U Barnikol; N Hilschmann
Journal:  Biol Chem Hoppe Seyler       Date:  1994-08

Review 6.  Targeting apoptosis in cancer therapy.

Authors:  Benedito A Carneiro; Wafik S El-Deiry
Journal:  Nat Rev Clin Oncol       Date:  2020-03-23       Impact factor: 66.675

7.  Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.

Authors:  Maryam N Alotibi; Amina M Alnoury; Amani M Alhozali
Journal:  Saudi Med J       Date:  2019-01       Impact factor: 1.484

Review 8.  Endoplasmic reticulum stress signals in the tumour and its microenvironment.

Authors:  Xi Chen; Juan R Cubillos-Ruiz
Journal:  Nat Rev Cancer       Date:  2020-11-19       Impact factor: 60.716

Review 9.  Recent insights into the function of autophagy in cancer.

Authors:  Ravi Amaravadi; Alec C Kimmelman; Eileen White
Journal:  Genes Dev       Date:  2016-09-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.